According to recent research, astrocyte cell transplantation could revolutionize treatments for neurological disorders such ...

In the race against time that characterizes ALS diagnosis and treatment, researchers have made a breakthrough that could dramatically change how we identify this devastating neurological disease. A ...

There’s still a lot we don’t know about how Parkinson’s disease develops. But one lifestyle intervention already has strong evidence behind it.

(Image Credits: Pixabay) Parkinson’s disease (PD) therapeutic landscape is heavily genericized, leaving substantial unmet needs in neuroprotective and disease-modifying therapies (DMTs). With current ...

Engineered polymers interfere with protein interactions to protect cell health in a mouse study. Researchers at Northwestern ...

Experts made the discovery after analysing hours of YouTube footage of celebrities with the disease - and it paves the way ...

Zizyphi spinosi semen demonstrates neuroprotective effects, improving cognitive function and reducing amyloid and tau pathology in models of aging and dementia.

Subscribe to Here’s the Deal, our politics newsletter for analysis you won’t find anywhere else.

Parkinson’s Disease (PD) is a common brain disorder that affects movement and is most often linked with aging. It’s the second most common age-related brain disease, affecting millions worldwide.

The research team suggests that the treatment can help address very early stages of a condition such as Alzheimer’s or ...

Global Central Nervous System Therapeutics Market is valued at approximately USD 143.95 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 7.5% over the forecast period ...

The brain, traditionally considered an immune-privileged organ due to the blood-brain barrier (BBB), has its own sophisticated immune defense system.